Fig. 1
From: ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma
ELF5 is the potential tumor suppressor gene in RCC. (A) GSE100666 dataset showed the KIRC samples (GSM2690785, GSM2690786, and GSM2690787) and paracancerous tissue samples (GSM2690788, GSM2690789, and GSM2690790). The ordinate represented the overall expression level of all samples (B) The volcano map of GSE100666. (C) One thousand and seventy differentially expressed genes were screened out. (D) The heat map of genes. (E) GSE100666 dataset showed ELF5 expression in KIRC and non-tumoral tissues, and the ordinate represented the expression level of ELF5 in 6 samples. (F) UALCAN database showed ELF5 expression in TCGA-KIRC and non-tumoral tissues. (G) The pan-cancer analysis showed ELF5 expression in different cancers. (H) ELF5 expression in the cancer stages, tumor grades, nodal metastasis status, and KIRC subtypes. (I) The survival analysis of patients with high/low ELF5 and different tumor grades. Two-tailed Student’s t test was performed. The error bars represent SD. ***p < 0.001